Inverse agonistic anti-US28 antibodies

Decreased adhesivity receptor-targeted nanoparticles for Fn14-positive tumors

ANTIBODY OR ANTIBODY COMBINATION AND METHOD USING SAME FOR DETECTION OF AN ANTIGEN RELATED TO MYCOBACTERIUM IN A URINE SAMPLE OF A SUBJECT

Compositions and methods to regulate Renalase in the treatment of cancer

Anti-HER2/anti-4-1BB bispecific antibody and use thereof

Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy

Targeted CD73 antibody and antibody-drug conjugate, and preparation method therefor and uses thereof

CD38 protein antibody and application thereof

Anti-OX40 antibodies and methods of activating OX40

METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH

Guidance and Navigation Control proteins and method of making and using thereof

Binding molecules specific for ASCT2 and uses thereof

IL-1β neutralizing human monoclonal antibodies

Anti-PfRH5 antibodies and antigen-binding fragments thereof

Fusion proteins for ophthalmology with increased eye retention

Anti-Tau antibodies and uses thereof

Human antibodies to Ebola virus glycoprotein

HER2-targeting antigen binding molecules comprising 4-1BBL

Disruption of the WAVE3 protein complex for suppression of invasion and metastasis

Activatable antibodies that bind epidermal growth factor receptor and methods thereof

Multifunctional immune cell therapies

IGF-1R ANTIBODY AND ITS USE FOR THE DIAGNOSIS OF CANCER

Haemorrhagic disorder due to ventricular assist device

ANTI-TNFRSF25 ANTIBODIES

Antibodies binding to vista at acidic pH

Targeted binding agents against B7-H1

Single-domain antibodies against LAG-3 and uses thereof

Anti-TIGIT antibodies

Anti-siglec-5 antibodies and methods of use thereof

ANTIGEN BINDING PROTEINS TO ONCOSTATIN M (OSM)

Biopharmaceutical compositions comprising nucleic acids encoding IL-5 binding proteins

Anti-CCL17 antibodies

Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof

Methods of detecting polyubiquitin using anti-polyubiquitin antibodies

Compositions and Methods for Treating and Preventing Staphylococcus Aureus Infections

Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of use

NUCLEIC ACID MOLECULES AND APPLICATIONS THEREOF IN PREPARING HUMAN SINGLE-DOMAIN ANTIBODY

Anti-GITR antibodies for cancer diagnostics

Glycan-Interacting Compounds and Methods of Use

Recombinant Cell Surface Capture Proteins

Anti-CD39 antibodies

Anti-CD27 Antibody, Antigen-binding Fragment Thereof, and Medical Use Thereof

Anti-CD25 for tumour specific cell depletion

Anti-CD25 for tumour specific cell depletion

Anti-CD25 for tumour specific cell depletion

Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein

Anti-CD25 antibody agents

High affinity antibodies to human IL-6 receptor

Trispecific antagonists

Anti C-MET antibodies

Antibody specifically binding to FOLR1 and uses thereof

Anti-troponin T antibodies

Humanized tau antibodies in Alzheimer's disease

Antibodies to amyloid beta

HIV Binding Agents

C-TERMINALLY FUSED TNF FAMILY LIGAND TRIMER-CONTAINING ANTIGEN BINDING MOLECULES

Treatment and Prophylaxis of Amyloidosis

Multivalent binding molecules

Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

Anti-folate receptor 1 antibodies and uses thereof

Anti-interleukin-33 antibodies and uses thereof

Human neutralizing anti-tetanus toxin monoclonal antibody and its applications

Methods and composition for neutralization of influenza

Antagonists targeting the TGF-β pathway

Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof

Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof

Human mesothelin chimeric antigen receptors and uses thereof

CD137 antibodies for T-cell activation

Anti-CD25 antibody agents

Bispecific antibody for ICOS and PD-L1

Combination therapies targeting PD-1, TIM-3, and LAG-3

Monoclonal antibody against human LAG-3, method for preparing the same, and use thereof

Conditionally active polypeptides

BISPECIFIC ANTIBODIES TO MOSPD2 AND T CELL- OR NK CELL-SPECIFIC MOLECULES

Calcitonin gene-related peptide (CGRP) antagonist antibodies

Anti-TAUC3 antibodies and uses thereof

Antibodies to surface determinants

Therapeutic antibodies to Marburg virus

CKIT antibody drug conjugates

Cytotoxic benzodiazepine derivatives

Polynucleotides encoding anti-C1s antibodies

CD5 CHIMERIC ANTIGEN RECEPTOR FOR ADOPTIVE T CELL THERAPY

Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors

Antibody therapeutics that bind CD38

Anti-CD38 antibodies and formulations

Antibodies against OX-40 and uses thereof

Anti-TrkB antibodies

PD-L1 antibody, antigen-binding fragment thereof and medical application thereof

Anti-PD-1 antibodies and uses thereof

Anti-CD47 antibodies and uses thereof

Anti-CXCL13 antibodies

COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF

Anti-TGF-beta antibodies and their use

Synthetic antibodies to BAX and uses thereof

CAR-T CELLS AND AUTOIMMUNE DISEASES

Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

Protease inhibitory antibodies and methods of use thereof

Antibodies to human B7x for treatment of metastatic cancer

Therapeutic molecules

CD73 blockade

HUMAN TNFRSF25 ANTIBODY

ALK7 binding proteins and uses thereof

IL-18 binding protein (IL-18BP) in inflammatory diseases

Compositions and methods for reducing at least one symptom of human allergy to cats

Human-derived anti-huntingtin (HTT) antibodies and uses thereof

Anti-PcrV antibodies that bind PcrV, compositions comprising anti-PcrV antibodies, and methods of use thereof

COMPOSITIONS TO DISRUPT PROTEIN KINASE A ANCHORING AND USES THEREOF

MULTISPECIFIC PROTEINS

Humanized antibodies targeting human tissue factor

Anti-KIT antibodies and uses thereof

HUMAN MONOCLONAL ANTI-PD-L1 ANTIBODIES AND METHODS OF USE

Anti-OX40 binding proteins

Antibody

Anti-C10orf54 antibodies and uses thereof

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES

Release segments and binding compositions comprising same

T cell receptors and immune therapy using the same

Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), and uses thereof

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Anti-claudin 18.2 antibodies and uses thereof

THERAPEUTIC ANTIBODIES FOR TREATMENT OF NEURODEGENERATION

Methods for reducing migraine frequency in a subject in need thereof

MODIFIED BISPECIFIC T CELL RECEPTORS

Immunoglobulins and uses thereof

CELL/TISSUE-SPECIFIC CELL-PENETRATING ANTIBODIES

Polynucleotides encoding a humanized anti-CD40 antibody

Cell-based assay for detecting anti-CD3 homodimers

VL ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS

Anti-survivin antibodies for cancer therapy

Anti-jagged antibodies and methods of use

Agonistic antibodies that bind human CD40 and uses thereof

IL-11RA ANTIBODIES

Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof

Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof

Antigen-binding molecule comprising altered antibody variable region binding CD3 and CD137

Humanized antibodies for CD3

Anti-CD47 antibody and use thereof

Multispecific antibodies that target HIV GP120 and CD3

VH-VL INTERDOMAIN ANGLE BASED ANTIBODY HUMANIZATION

Method of treatment of a tumor with an IL-8 antibody

IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases

COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES

NEUTRALISING ANTIBODIES TO THE MAJOR EXOTOXINS TCDA AND TCDB OF CLOSTRIDIUM DIFFICILE

Human antibodies to influenza hemagglutinin

Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof

Animal Models and Therapeutic Molecules

METHOD FOR SCREENING THE ACTIVITY OF EXPRESSED POLYPEPTIDES

Method for generating high affinity antibodies

Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases

Method for treating cancer using anti-CD137 antibody

IL-6R ANTIBODY AND ANTIGEN BINDING FRAGMENT THEREOF AND MEDICAL USE

Anti-human PD-L2 antibodies

MULTISPECIFIC ANTIGEN BINDING PROTEINS AND METHODS OF USE THEREOF

Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies

Combination therapy using antibody to human Siglec-9 and antibody to human NKG2A for treating cancer

Anti-STAT3 bispecific antibody having cell-penetrating ability, and pharmaceutical composition containing same

Monoclonal antibodies against pathological alpha-synuclein, and methods using same

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD2+ CELLS

Anti-PD-1 antibodies and methods of use thereof

Methods of identifying HIV patients sensitive to therapy with GP120 V3 glycan-directed antibodies

Methods for expansion or depletion of T-regulatory cells

Anti-dengue virus NS1 protein monoclonal antibodies

Acceptor Framework for CDR Grafting

CD38 antibody

Single domain antibodies that bind to CD137

IL-17 receptor A antigen binding proteins

Humanized anti-CCR7 receptor antibodies

IgG Fc variants for veterinary use

Ultra-potent neutralization of GM-CSF by multispecific antibodies and uses thereof

MULTISPECIFIC ANTIGEN-BINDING MOLECULES HAVING BLOOD COAGULATION FACTOR VIII (FVIII) COFACTOR FUNCTION-SUBSTITUTING ACTIVITY AND PHARMACEUTICAL FORMULATIONS CONTAINING SUCH A MOLECULE AS AN ACTIVE INGREDIENT

Antibodies targeting glioblastoma stem-like cells and methods of use thereof

Anti-IL-6/IL-6R antibodies and methods of use thereof

ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES

Anti-CTLA-4 antibodies and methods of use thereof

Anti-PD-1 antibodies and methods of use thereof

Antibodies against canine PD-1

Human antibodies binding to ROR2

Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab

Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof

Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof

XCR1 BINDING AGENTS AND USES THEREOF

Polynucleotides encoding IL33 antibodies and methods of using the same

Anti-folate receptor alpha antibody conjugated with hemiasterlins

Animal Models and Therapeutic Molecules

Animal Models and Therapeutic Molecules

4-1BB antibody and preparation method and use thereof

NOVEL TNFR AGONISTS AND USES THEREOF

BISPECIFIC ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

Single-domain antibodies and variants thereof against PD-1

CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof

IL-17A binding proteins

Genetically modified non-human animals and methods for producing heavy chain-only antibodies

Fully humanized anti-B cell maturation antigen (BCMA) single-chain antibody and use thereof

Anti-GITR antibodies and methods of use thereof

Methods of producing an IL-1 RAP antibodies

SOLUBLE HUMAN ST-2 ANTIBODIES AND ASSAYS

PD-L1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereof

Antibodies to LILRB2

Antibody molecules to PD-1 and uses thereof

CD3-DELTA/EPSILON HETERODIMER SPECIFIC ANTIBODIES

Anti-CD83 antibodies and use thereof

ANTIGEN BINDING MOLECULES TO TIGIT

Anti-RSV monoclonal antibody formulation

Fibronectin binding domains with reduced immunogenicity

Animal Models and Therapeutic Molecules

Diagnostic Assays and Kits for Detection of Folate Receptor 1

Compositions and methods for treating IgE-mediated disorders

Inert format

Antibodies targeting CD137 and methods of use thereof

Bispecific antibodies binding ALK-1 and BMPR-2

Anti-PD-1 antibodies and uses thereof

Anti-CD73 antibodies and uses thereof

Monoclonal antibodies that bind TRBV9 and methods for using same for inhibiting the T cell receptor for treatment

Antibody constructs for DLL3 and CD3

Antibodies against 4G7-derived chimeric antigen receptors

Method of Treating Psoriasis in Pediatric Subjects with Anti-IL12/IL23 Antibody

Antibody molecules to a proliferation-inducing ligand (APRIL)

Anti-transthyretin antibodies

Treating headache comprising administering an antibody to calcitonin gene-related peptide

Hemagglutinin-specific antibodies and uses thereof

HUMAN ANTIBODIES TO PD-1

Anti-tryptase antibodies, compositions thereof, and uses thereof

Antibodies for botulinum neurotoxins

GALACTOENGINEERED IMMUNOGLOBULIN 1 ANTIBODIES

Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody

Variant nucleic acid libraries for GLP1 receptor

Killer cell lectin-like receptor subfamily G member 1 (KLRG1) depleting antibodies

Binding molecules that modulate a biological activity expressed by a cell

ANTIBODIES BINDING TO HUMAN AND CYNOMOLGUS CD3 EPSILON

Methods of treatments using antigen-binding proteins targeting CD56

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

ANTI-TRAIL ANTIBODIES AND METHODS OF USE

THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING MOLECULES AND METHODS OF USING THE MOLECULES

Anti-HSA antibodies

Tumor-selective CTLA-4 antagonists

VEGFR-antibody light chain fusion protein

Nucleic acid encoding PCSK9 antibody

METHOD FOR EXPRESSING AND PREPARING POLYVALENT MULTI-SPECIFIC ANTIBODY AND IMMUNE HYBRID PROTEIN

REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIa ANTIBODIES AND USES THEREOF

Anti-coagulation factor XI antibodies

Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof

ANTI-PD-1 ANTIBODIES AND THEIR USES

Optimized antibodies that target CD19

ADAMTS binding immunoglobulins

Human Monoclonal Antibodies Against CD20

Methods of administering anti-OX40 antibodies

Nucleic acids encoding anti-CD154 antibodies

ANTI-HLA-DQ2.5 ANTIBODY

Compositions and methods for immunotherapy

Anti-TREM2 antibodies and methods of use thereof

ANTI-HUMAN CD19 ANTIBODIES WITH HIGH AFFINITY

Anti-ACTH antibodies and use thereof

Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)

Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use

Anti-complement factor C1q Fab fragments and uses thereof

Antibodies recognizing alpha-synuclein

Multispecific binding molecules having specificity to dystroglycan and laminin-2

Compositions and methods for antibodies targeting staphylococcal leukotoxins

Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv

T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptides

Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

TfR selective binding compounds and related methods

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Therapeutic antibodies against ROR-1 protein and methods for use of same

Variant nucleic acid libraries for antibody optimization

Humanised ADAMTS13 binding antibodies

Anti-coagulation factor XI antibodies

REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIA ANTIBODIES AND USES THEREOF

ANTI-GPC-1 ANTIBODY

Anti-LY6H antibodies and antibody drug conjugates

Anti-C3d antibody conjugates and methods of detecting complement activation

Carrier-binding agent compositions and methods of making and using the same

CD137 antibodies and tumor antigen-targeting antibodies and uses thereof

METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS

Anti-CD115 antibodies

ANTI-CD25 ANTIBODIES AND THEIR USES

WNT surrogate molecules and uses thereof

Antibody molecules to TIM-3 and uses thereof

HER3 antigen-binding molecules

ANTI-IL-33 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF

Stabilized chimeric Fabs

Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

Antibodies to pyroglutamate amyloid-β and uses thereof

Anti-Her2 single chain antibody and coding sequence and use thereof

Antibodies that specifically bind alpha klotho

Stable multispecific antibodies

Anti-CD3 antibodies and methods of use

Anti-CD3 antibodies and methods of use

TRISPECIFIC ANTIBODIES SPECIFIC FOR HER2 AND A BLOOD BRAIN BARRIER RECEPTOR AND METHODS OF USE

Anti-ErbB3 antibodies

Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use

Blood-Brain Barrier Shuttles Containing Antibodies Recognizing Alpha-Synuclein

Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers

PDGF receptor beta binding polypeptides

EGFR × CD28 multispecific antibodies